Tracey C. Fleischer, Ph.D. - Publications

Affiliations: 
2003 University of Utah, Salt Lake City, UT 
Area:
Molecular Biology, Oncology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Markenson GR, Saade GR, Laurent LC, Heyborne KD, Coonrod DV, Schoen CN, Baxter JK, Haas DM, Longo S, Grobman WA, Sullivan SA, Major CA, Wheeler SM, Pereira LM, Su EJ, ... ... Fleischer TC, et al. Performance of a proteomic preterm delivery predictor in a large independent prospective cohort. American Journal of Obstetrics & Gynecology Mfm. 2: 100140. PMID 33345877 DOI: 10.1016/j.ajogmf.2020.100140  0.306
2020 Link AJ, Niu X, Weaver CM, Jennings JL, Duncan DT, McAfee KJ, Sammons M, Gerbasi VR, Farley AR, Fleischer TC, Browne CM, Samir P, Galassie A, Boone B. Targeted identification of protein interactions in eukaryotic mRNA translation. Proteomics. e1900177. PMID 32027465 DOI: 10.1002/Pmic.201900177  0.355
2017 Bradford C, Severinsen R, Pugmire T, Rasmussen M, Stoddard K, Uemura Y, Wheelwright S, Mentinova M, Chelsky D, Hunsucker SW, Kearney P, Hickok D, Fleischer TC, Ichetovkin I, Boniface JJ, et al. Analytical validation of protein biomarkers for risk of spontaneous preterm birth Clinical Mass Spectrometry. 3: 25-38. DOI: 10.1016/J.Clinms.2017.06.002  0.325
2011 Boniface JJ, Baichwal VR, Cimbora DM, DeMie L, Fleischer TC, Gassman AD, Ghaffari S, Green JP, Flick JS, Terry-Lorenzo RT, Papac DI, Peterson A, Robinson R, Carlson RO. Abstract 577: Basal NAD levels and Nampt expression correlate with in vitro and in vivo sensitivity of tumor cell lines to the Nampt inhibitor MPC-9528 Cancer Research. 71: 577-577. DOI: 10.1158/1538-7445.Am2011-577  0.318
2011 Terry-Lorenzo RT, Douce TB, Austin HA, Boniface JJ, Cimbora DM, Fleischer TC, Carlson RO. Abstract 2551: The Nampt inhibitor MPC-9528 synergizes with DNA damaging agents Cancer Research. 71: 2551-2551. DOI: 10.1158/1538-7445.Am2011-2551  0.304
2010 Lockman JW, Murphy BR, Zigar DF, Judd WR, Slattum PM, Gao ZH, Ostanin K, Green J, McKinnon R, Terry-Lorenzo RT, Fleischer TC, Boniface JJ, Shenderovich M, Willardsen JA. Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt). Journal of Medicinal Chemistry. 53: 8734-46. PMID 21080724 DOI: 10.1021/Jm101145B  0.304
2010 Fleischer TC, Murphy BR, Flick JS, Terry-Lorenzo RT, Gao ZH, Davis T, McKinnon R, Ostanin K, Willardsen JA, Boniface JJ. Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. Chemistry & Biology. 17: 659-64. PMID 20609415 DOI: 10.1016/J.Chembiol.2010.05.008  0.337
2010 Fleischer TC, Baichwal VR, Bradford CL, Demie L, Green JP, Hess MA, Lockman JW, McKinnon R, Ostanin K, Papac DI, Reeves LF, Terry-Lorenzo RT, Willardsen JA. Abstract LB-288: MPI-0486348: A novel inhibitor of nicotinamide phosphoribosyltransferase (Nampt) induces tumor regression in a preclinical model Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-288  0.327
2010 Fleischer TC, Flick JS, Terry-Lorenzo RT, Gao Z, Murphy BR, Willardson JA, Boniface JJ. Abstract 3673: Identifying the target of an orphan compound: CB30865 is a Nampt inhibitor Cancer Research. 70: 3673-3673. DOI: 10.1158/1538-7445.Am10-3673  0.367
2006 Fleischer TC, Weaver CM, McAfee KJ, Jennings JL, Link AJ. Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes. Genes & Development. 20: 1294-307. PMID 16702403 DOI: 10.1101/Gad.1422006  0.382
2005 Link AJ, Fleischer TC, Weaver CM, Gerbasi VR, Jennings JL. Purifying protein complexes for mass spectrometry: applications to protein translation. Methods (San Diego, Calif.). 35: 274-90. PMID 15722224 DOI: 10.1016/J.Ymeth.2004.08.019  0.368
2004 Lewis PW, Beall EL, Fleischer TC, Georlette D, Link AJ, Botchan MR. Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes & Development. 18: 2929-40. PMID 15545624 DOI: 10.1101/Gad.1255204  0.447
2003 Fleischer TC, Yun UJ, Ayer DE. Identification and characterization of three new components of the mSin3A corepressor complex. Molecular and Cellular Biology. 23: 3456-67. PMID 12724404 DOI: 10.1128/Mcb.23.10.3456-3467.2003  0.582
1998 Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proceedings of the National Academy of Sciences of the United States of America. 95: 3519-24. PMID 9520398 DOI: 10.1073/Pnas.95.7.3519  0.581
1997 Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell. 89: 341-7. PMID 9150133 DOI: 10.1016/S0092-8674(00)80214-7  0.6
Show low-probability matches.